The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 28, 2006
Filed:
Jan. 10, 2003
Rando Allikmets, Frederick, MD (US);
Kent L. Anderson, Houston, TX (US);
Michael Dean, Frederick, MD (US);
Mark Leppert, Salt Lake City, UT (US);
Richard A. Lewis, Houston, TX (US);
Yixin LI, Houston, TX (US);
James R. Lupski, Houston, TX (US);
Jeremy Nathans, Baltimore, MD (US);
Amir Rattner, Baltimore, MD (US);
Noah F. Shroyer, Houston, TX (US);
Nanda Singh, Salt Lake City, UT (US);
Philip Smallwood, Woodbine, MD (US);
Hui Sun, Baltimore, MD (US);
Rando Allikmets, Frederick, MD (US);
Kent L. Anderson, Houston, TX (US);
Michael Dean, Frederick, MD (US);
Mark Leppert, Salt Lake City, UT (US);
Richard A. Lewis, Houston, TX (US);
Yixin Li, Houston, TX (US);
James R. Lupski, Houston, TX (US);
Jeremy Nathans, Baltimore, MD (US);
Amir Rattner, Baltimore, MD (US);
Noah F. Shroyer, Houston, TX (US);
Nanda Singh, Salt Lake City, UT (US);
Philip Smallwood, Woodbine, MD (US);
Hui Sun, Baltimore, MD (US);
University of Utah Research Foundation, Salt Lake City, UT (US);
Baylor College of Medicine, Houston, TX (US);
John Hopkins University, Baltiomore, MD (US);
The United States of America as represented by the Department of Health and Human Services, Washington, DC (US);
Abstract
The present invention provides nucleic acid and amino acid sequences of an ATP binding cassette transporter and mutated sequences thereof associated with macular degeneration. Methods of detecting agents that modify ATP-binding cassette transporter comprising combining purified ATP binding cassette transporter and at least one agent suspected of modifying the ATP binding cassette transporter an observing a change in at least one characteristic associated with ATP binding cassette transporter. Methods of detecting macular degeneration is also embodied by the present invention.